Neon Therapeutics

July 15, 2019

Neon shines, but larger trials needed to illuminate full effect

Neon's cancer vaccine makes a decent early showing, but overall survival remain a crucial measure.

July 12, 2019

Neon and Neurotrope await signs of proof of concept

Neon Therapeutics is due to unveil the first rigorous test of its neoantigen approach to fighting tumours, while Neurotrope makes a brave bid in Alzheimer's.

July 02, 2018

June rush drives near-record quarter for biotech flotations

Biotech IPOs raised a huge $2.3bn on Western exchanges in the second-quarter of 2018, as private companies rushed to market ahead of the summer lull.

Neon Therapeutics

Neon shines, but larger trials needed to illuminate full effect

Neon and Neurotrope await signs of proof of concept

June rush drives near-record quarter for biotech flotations

Latest Reports

Evaluate Vantage Pharma, Biotech & Medtech 2019 in Review

Evaluate Vantage 2020 Preview

Editor's Picks

A Covid-19 treatment plan slowly emerges

Tiziana takes a deep breath and targets Covid-19

Estimating the cost of Covid-19 antiviral development

Few groups have developed Covid-19 diagnostics – but this will change

Clinical trial delays become reality as Covid-19 risk spreads